Clinical Trial Update: Cardenilimab Combined With Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cardenilimab in combination with chemotherapy for locally advanced esophageal squamous cell carcinoma is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Cardenilimab
• Chemotherapy (unspecified regimen)

Snippet

Sponsor: Li Zhang | Conditions: Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapies | Phase 2 | Status: RECRUITING